Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.274NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.515NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.515NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.515NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.258.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.258.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.370NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.370NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.370NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.118NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.118NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.118NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.137NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.137NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-10257.2Singapore
B.1.137NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.309NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.309NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.309NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.632NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.632NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.632NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.72NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.72NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.72NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.108NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.108NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.108NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.332NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.332NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.332NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.30NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.30NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.30NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.38.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.38.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.38.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N/ANUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N/ANYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N/ANChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used